Resources

Amid ongoing geopolitical uncertainty, the UK life sciences ecosystem is keeping calm and carrying on.

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapy products for the treatment of multiple cancers, announces a partnership with the NHS Cancer Vaccine Launch Pad (CVLP) to fast-track access for NHS patients into the fourth cohort of the Company’s Phase 2 clinical SCOPE study. 

Intracellular Drug Delivery Centre has developed the Quick Start Guide with input from MHRA.

Since joining the TechBio Boost programme, SokerData refined their business model, adopted a more strategic approach to market entry, built new partnerships and are securing funding to accelerate R&D and commercialisation.

Myricx Bio (‘Myricx’ is pleased to announce team expansion, with the appointment of Steen Lisby, M.D., D.MSc. as CMO and Jesper Valbjørn, M.Sc. as SVP CMC.

eXmoor Pharma, a full-service Cell and Gene Therapy (CGT) CDMO, has appointed Dr James Miskin as Non-Executive Director.

The agreement is expected to serve as a critical foundation for activating international joint research, academic exchange and research collaboration in quantum fields, including quantum computing.

Coulter Partners successfully completed a search assignment for iOnctura and is pleased to announce the placement of Dr. Mark Velleca as Chair of the Board of Directors.

The workshop brought together leading academic researchers, industry experts and innovators to explore the fundamentals of AlphaFold – an artificial intelligence (AI) program developed by Google DeepMind to predict the 3D structure of proteins.

In this blog, Dr Emma Lawrence, Head of data tech policy and public affairs at BIA, writes about the UK government's recent £600 million initiative to launch a Health Data Research Service which aims to revolutionize access to NHS data and tackle longstanding governance and technical hurdles.

Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatments.

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board.

Cancer Research Horizons has announced a collaboration with Histofy to develop tools that predict how colorectal cancer patients respond to different treatment options using the multi-modal S:CORT dataset.

Change is happening fast for our sector at the moment, and I expect to see big calls from the UK government as it responds to global events this week.

Judges lauded the cutting-edge CRO, RSSL, for its exceptional service to over 3,000 clients in 60+ countries, alongside its continued investment in services, technology and team.

Andrew Merrison from FI Group shares his knowledge about the new rule changes HMRC has put in place concerning overseas costs about biotech.

Coulter Partners successfully completed a search assignment for Altimmune Inc. (Nasdaq: ALT), and is pleased to announce the placement of biopharmaceutical industry executives Teri Lawver and Jerry Durso to its Board of Directors.

Will James and Robyn Trigg from Osborne Clarke look at how the UPC's practice and procedure has developed since it began operations in June 2023.